RAPT Therapeutics, Inc. (RAPT) Payables (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Payables for 5 consecutive years, with $1.4 million as the latest value for Q3 2024.
- Quarterly Payables fell 73.95% to $1.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Sep 2024, down 73.95% year-over-year, with the annual reading at $5.2 million for FY2023, 53.82% up from the prior year.
- Payables hit $1.4 million in Q3 2024 for RAPT Therapeutics, down from $2.7 million in the prior quarter.
- In the past five years, Payables ranged from a high of $8.9 million in Q1 2023 to a low of $1.4 million in Q3 2024.
- Historically, Payables has averaged $3.7 million across 5 years, with a median of $3.4 million in 2022.
- Biggest five-year swings in Payables: soared 361.83% in 2023 and later plummeted 73.95% in 2024.
- Year by year, Payables stood at $2.4 million in 2020, then dropped by 16.11% to $2.0 million in 2021, then skyrocketed by 68.33% to $3.4 million in 2022, then skyrocketed by 53.82% to $5.2 million in 2023, then plummeted by 73.34% to $1.4 million in 2024.
- Business Quant data shows Payables for RAPT at $1.4 million in Q3 2024, $2.7 million in Q2 2024, and $6.8 million in Q1 2024.